The transforming growth factor beta (TGF-β) family of ligands plays major roles in embryonic development, tissue homeostasis, adult immunity, and wound repair. Dysregulation of TGF-β signaling pathway leads to severe diseases. Its key components have been revealed over the past two decades. This family of cytokines acts by activating receptor activated SMAD (R-SMAD) transcription factors, which in turn modulate the expression of specific sets of target genes. Cells of a multicellular organism have the same genetic information, yet they show structural and functional differences owing to differential expression of their genes. Studies have demonstrated that epigenetic regulation, an integral part of the TGF-β signaling, enables cells to sense and respond to TGF-β signaling in a cell context-dependent manner. R-SMAD, as the central transcription factor of TGF-β signaling, can recruit various epigenetic regulators to shape the transcriptome. In this review, we focus on epigenetic regulatory mechanisms in the TGF-β signaling during mammalian development and diseases and discuss the central role of the interaction between R-SMAD and various epigenetic regulators in this epigenetic regulation. The crosstalk between TGF-β signaling and the epigenome could serve as a versatile fine-tuning mechanism for transcriptional regulation during embryonic development and progression of diseases, particularly cancer.
Introduction
Transforming growth factor beta (TGF-β) signaling, elicited by a superfamily of ligands that includes TGF-β itself, nodal, activin, bone morphogenetic proteins (BMP), growth and differentiation factor, and Müllerian inhibiting substance (MIS), plays major roles in embryonic development, tissue homeostasis, adult immunity, and wound repair [1] [2] [3] [4] [5] [6] [7] [8] . In the canonical TGF-β signaling pathway, these ligands trigger the assembly, on the cell membrane, of receptor heterotetramers, which consist of two Type I receptors and two Type II receptors. Different combinations of the receptors are also regulatory platform for integrating the stimuli from BMP and TGF-β signals [9] . Both types of receptors have Ser/Thr protein kinase activities. After being phosphorylated by Type II receptor kinase activity stimulated by ligand binding, Type I receptor can switch its binding partner from the signal silencer FKBP12 to the signal transducer SMAD [10] . This binding partner switch converts the extracellular signal of ligands to an intracellular signal cascade. The ligand-activated receptor kinase phosphorylates and activates R-SMADs. TGF-β, nodal, and activin receptors phosphorylate SMAD2/3, and BMP receptors phosphorylate SMAD1/5/8. The phosphorylated R-SMADs then bind SMAD4 and translocate to the nucleus to regulate gene transcription [9] . Therefore, R-SMAD is the pivotal regulator of TGF-β signaling. R-SMAD has two globular domains (termed MHI domain and MHII domain) coupled by an unstructured linker. The MHI domain is at the amino terminal of the SMAD protein and its hairpin structure is capable of recognizing specific nucleotide sequence motif [11, 12] . MHII domain at the carboxyl terminal of R-SMAD has the SSXS motif whose phosphorylation by Type I receptor activates R-SMAD [13] . The MHII domain, once in nucleus, recruits various nuclear proteins including transcriptional activators and epigenetic regulators to TGF-β signaling target genes and thereby dictates spatial and temporal expression of these target genes ( Fig. 1 ) [14] [15] [16] [17] .
About six decades ago, Waddington [18] proposed the epigenetic landscape model of development. He envisioned development starts with a marble representing a totipotent zygote cell at the top of a hill (Fig. 2) . After the marble rolls down the hill, it enters a series of furrows that represent increasing restrictive and committed cell fates from a totipotent state to a pluripotent state, and then to a multipotent state, finally to a terminal state, i.e. terminally differentiated cells of adult tissue. He speculated that the different cell populations through the trip in the valley are further associated with specific epigenetic status. Recent reprogramming experiments pioneered by Yamanaka indicate the terminally differentiated cell can be coerced to reverse uphill to stem cells [19] and the induced pluripotent stem cells (iPS) has its unique epigenetic landscape, which has epigenetic memory of its donor cells [20, 21] . Beginning at the turn of the 21st century, next generation of high-throughput sequencing technology has facilitated rapid elucidation of main epigenetic landscape including nucleosome positioning, histone modifications, DNA methylation, and long non-coding RNAs (lncRNAs) across the genome of many different cell types. For the past three decades, we learned that cell signaling, such as TGF-β signaling often combines with other signalings, plays essential roles in development and disease progression (Fig. 2) [22] [23] [24] [25] . Several studies demonstrated that epigenetic regulator can direct target TGF-β superfamily ligands or pathway components to regulate early development and stem cell differentiation [26] [27] [28] . Yet, the critical question of how does cell signaling crosstalk with epigenome to regulate gene expression during development and disease progression has been less well studied. In this review, we focus on epigenetic regulators that are recruited or activated by R-SMAD in responsive to TGF-β signaling and mechanisms of how they regulate transcription in a cell context-dependent manner (Fig. 1) . We will discuss the involvement of chromatin Figure 1 . Involvement of epigenetic regulators in SMAD-dependent transcriptional regulation The signaling ligand dimmer (TGF-β and BMP) from extracellular matrix bind to Type II receptor and trigger its dimerization and sequential activation of Type I receptor, and then the GS region of Type I receptor phosphorylate signaling transducer (R-SMAD) which can subsequently recruit Co-SMAD to form activated SMAD complex. When activated SMAD complex translocates from the cytosol into the nucleus, it can recruit various epigenetic regulators, such as histone modifiers, DNA modifiers, nucleosome remodelers, and lncRNAs, to regulate the transcription of cell context-dependent TGF-β signaling target genes.
remodelers, histone modifiers, DNA modifiers, chromatin readers, and lncRNAs in TGF-β signaling and reveal how the crosstalk between TGF-β signaling and epigenome determines the versatile functions of the TGF-β signaling.
SMAD and Chromatin Remodelers
Chromatin remodelers have been shown to play essential roles in regulation of gene transcription, and activation of many eukaryotic genes requires chromatin remodeling [29] . Without exception, transcription regulation in TGF-β signaling also requires chromatin remodeling, especially for regulation of genes involved in cell cycle and development [30, 31] . Xi et al. [32] demonstrated that the BRG1 SWI/SNF chromatin-remodeling complex is incorporated into the SMAD2/3-SMAD4 complexes at target gene promoters and is required for their TGF-β transcriptional responses. Although they showed the genome-wide BRG1 dependence of the TGF-β transcriptional program, the requirement of BRG1 is not universal, that is, some TGF-β target genes are regulated independently of BRG1. Furthermore, the recruitment of SMAD-BRG1 complexes to target promoters seems to be a general event in SMAD pathways whether or not transcription of target genes is dependent on SWI/SNF. Additionally, negative regulators such as SMAD7 and SNON are less dependent on SWI/SNF, suggesting promoters of these genes, which are accessible before TGF-β signaling, do not require actions of SWI/SNF and, therefore, can readily respond to TGF-β signaling. On the other hand, some lineage specific or cell type-specific TGF-β target genes' promoters might be inaccessible, which would necessitate the involvement of SWI/SNF in the regulation of their gene expression responding to TGF-β.
SMAD and Histone Modifiers

Histone acetylation
Since Allfrey et al. [33] first reported that histone acetylation plays a role in RNA biosynthesis in 1964, numerous studies have expanded study of histone acetylation to its roles in mammalian development and disease progression. The enzymes that catalyze histone acetylation and deacetylation are termed histone acetyltransferase (HAT) and histone deacetylase (HDAC), respectively. The HATs utilize acetyl-CoA as cofactor and catalyze transfer of an acetyl group to the ε-amino group of lysine side chain in histone [34] , and HDAC functions in an opposite manner and restores the positive charge of histone, which is believed to stabilize the local architecture of chromatin and to repress gene expression [35] .
The HATs can be categorized into two types: Type A and Type B. Type B HATs mainly localize in the cytoplasm and catalyze the transferring of acetyl groups to free histones rather than histones compacted in the chromatin. Type A HATs localize in the nucleus and seem to play a very important role in transcription regulation. They can be divided into three subtypes: GNAT, MYST, and CBP/ p300 families. All three groups of Type A HATs catalyze acetylation of the N terminal tail of histone neutralizing the positive charges and leading to disruption of stabilizing influence of electrostatic interactions [36] . These enzymatic activities are consistent with their function as transcriptional coactivators. Although a purified HAT alone can acetylate its substrate in the test tube, its function in vivo requires formation of a large protein complex with transcriptional activators. The complex is loaded onto chromatin at specific genomic regions such as enhancers or promoters. P300/CBP is the first transcriptional coactivator identified in TGF-β signaling [37] . It interacts with SMAD1,2,3,4,5 and these SMADs' MHII domains have been shown to directly interact with P300/CBP [37] [38] [39] . Based on these findings, a classical model of transcription regulation in TGF-β signaling has been proposed: the MHI domain binds to DNA with specific sequence motif, such as CAGAC, and MHII domain recruits HATs. Acetylation of histones by HATs remodels the epigenetic landscape around MHI binding sites rendering chromatin at this region more accessible. Interaction between P300/ CBP and SMAD has also been demonstrated to be regulated in a cell context-dependent manner [40] . For example, the melanocyte-specific MSG1 protein enhances the binding between SMAD4 and P300/CBP to boost transcription activation in TGF-β signaling [41] . However, MSG1 is not a general transcription activator for TGF-β signaling. It functions only at specific developmental stages as an amplifier of transcription activation of master regulator genes.
In addition, histone acetylation has been shown to bridge different signaling pathways. BMP and leukemia inhibitory factor (LIF) signaling pathways are both critical players in astrocyte differentiation. During astrocyte differentiation, the MHII domain of SMAD1 interacts with P300/CBP, and STAT3, the key transcription factor of LIF signaling also binds to P300/CBP. Therefore, P300/ CBP couples loading of both SMAD1 and STAT3 to the promoter region of the GFAP gene during fetal astrocyte development. Thus, these findings demonstrate that P300/CBP could serve as a converging point integrating different developing cues to trigger proper cell differentiation [42] . P300/CBP also acetylates R-SMADs and changes its transcriptional activity possibly by altering its DNA binding affinity. For example, the MHI domain of SMAD3 has been shown to be acetylated by P300/CBP upon TGF-β signaling, and this acetylation leads to a significant augment of the transcription of SMAD targeted genes [43] .
R-SMADs can also form complex with HDACs, which serve as a negative regulator of histone acetylation and thereby downregulates TGF-β responsive genes [44, 45] . In the nucleus, HDAC is the key enzymatic component of two major repressor complexes: NURD complex and Sin3A complex. Studies of HDAC knockout mice have indicated that these complexes function specifically in development, rather than being required for most cellular processes [46, 47] . These findings suggest that interaction dynamics among SMADs, HATs and HDACs are perhaps the determining factor of transcriptional output during specific development stages. Besides RSMADs, SKI, another key negative regulator in TGF-β signaling can also form complex with Sin3A/HDAC complex [48] .
In sum, in the cell nucleus, various types of R-SMAD centered complexes are quite dynamic, assembled or disassembled all the time. Yet, at some specific genomic loci, transcription regulators like HATs and HDACs can strongly influence transcriptional activity. Thus, the complex R-SMADs form with HATs (or HDACs) regulates transcription of specific target genes positively (or negatively), which could determine the cell fate.
Histone methylation
Methylation of histone H3 and H4 tails is another classical posttranslational modification that regulates chromatin conformation and transcriptional activity. Methylation status at different sites of histone can indicate either activation or inactivation of gene expression. In comparison to histone acetylation, mechanisms for imposing and erasing histone methylation marks are more complex and are catalyzed by a larger number of enzymes (histone methyltransferases and demethylases) [49] . Regulation of histone methylation plays important roles in many biological processes including development, stress response, and diseases such as cancer [50] [51] [52] [53] .
Histone demethylases have been demonstrated to be key players in controlling cell identity and development though functional requirements of their enzymatic activities are context dependent [52, [54] [55] [56] [57] [58] . Studies have shown that histone demethylases could regulate tissue specific genes not only through modifying the chromatin landscape and also by recruiting other epigenetic regulators and RNA Pol II to promoters of developmentally critical genes [59] [60] [61] . Histone demethylases influence TGF-β signaling pathways in two different ways: they can interact with R-SMAD or they can regulate the expression of other target genes after their expression is highly induced responding to TGF-β signaling. Here we take R-SMAD/KDM6B complex as an example. In mouse embryonic stem cells (mESCs), KDM6B has been reported to interact with SMAD1/5 or SMAD2/3 at promoter regions of Noggin or Nodal respectively, leading to upregulation of gene expression by relieving repressive effects of chromatin [62, 63] . In human embryonic stem cells, the optimal bivalent signature (H3K4me3 and H3K27me3) at 32 gene loci drives endoderm commitment. During the first 24 h of endodermal differentiation, upon activin A stimulation, increased SMAD2/3 occupancy at those loci coincides with H3K27me3 reduction and KDM6B recruitment to these promoters. This indicates that R-SMAD could regulate expression of developmental genes through crosstalk with chromatin [64, 65] . Interestingly, BMP signaling in mESCs and human bone marrow mesenchymal stem/stromal cells can induce expression of KDM6B, which in turn regulates specific developmental processes [66, 67] .
R-SMADs also form complexes with histone methyltransferase in a signal-dependent manner. SMAD1/5 binds to H3K9 methyltransferase Suv39h and thereby increases the local level of H3K9me3, leading to recruitment of the NURD complex and silencing of target genes by NURD [68] .
Enhancer of zeste homolog 2 (EZH2) is a histone-lysine N-methyltransferase, which is the functional enzymatic component of polycomb repressive complex 2 (PRC2). PRC2 regulates the expression of genes critical for development and differentiation [69] . In hESCs, the interaction between SMAD2 and EZH2 induced by activin A causes a decline of H3K27me3 levels through SMAD2-mediated reduction of the protein level of EZH2. This event is essential for mesendodermal differentiation [70] . Thus, in TGF-β signaling, not only are histone methyltransferases recruited to specific promoter regions, their activities are also modified in a signal-dependent manner.
SMAD and DNA Modifiers
Another well-characterized epigenetic modification, DNA methylation, happens directly on DNA, where cytosines are methylated at carbon 5 and typically in a CpG context to produce 5-methylcytosine (5mC). DNA methylation plays an important role in regulating gene transcription [71] [72] [73] [74] . Although DNA methylation has long been associated with gene silencing, the detailed mechanism of how it suppresses transcription in a locus specific manner remains unclear, neither does the mechanism of how DNA methylation is reversed.
Recent studies have shown that R-SMADs can promote locus specific, active DNA demethylation as part of the TGF-β transcriptional response. In proliferating epithelial cells, a protein complex consisting of ZNF217, CoREST, and DNMT3A is present at the promoter of tumor suppressor p15 ink4b gene and suppresses its expression. Upon TGF-β signaling, SMAD2/3, translocated from cytoplasm into nucleus, releases this transcription repressor complex from the promoter. It also recruits proteins that facilitate DNA demethylation including cytidine deaminase (AID), the DNA glycosylases (TDG), MBD4, and components of break excision repair pathway, thereby establishing the hypo-methylation landscape around p15 ink4b gene promoter region. Such hypo-methylated chromatin state renders the promoter region of p15 ink4b accessible to transcription factor FoxO and coactivator CBP [75] . Thus, local DNA demethylation promotes rapid induction of target genes in response to TGF-β. Similar mechanism has also been shown in transcriptional regulation during BMP signaling. When murine fibroblasts are reprogrammed to iPS cells, TDG, and ten eleven translocation (TET1), a methylcytosine dioxygenase that catalyzes the oxidation of 5mC to 5-hydroxymethylcytosine, are recruited by BMP-activated SMAD1 to the promoter region of the miR-200 cluster. The resulting DNA demethylation stimulates miR-200 expression, lack of which would stall reprogramming processs [76] . Analogous mechanisms are used to regulate the expression of GFAP during astrocyte differentiation. These findings suggest that the crosstalk between BMP signaling and DNA methylation can determine cell fates [77] .
It has been shown that TGF-β can induce global changes in DNA methylation during the epithelial-to-mesenchymal transition in ovarian cancer cells [78] . BMP signaling can also induce global changes in DNA methylation. For example, during primordial germ cell (PGC) differentiation, BMP together with LIF induces genomewide DNA demethylation and promotes cell fate transition [79, 80] . During this process, PGC differentiation master regulator genes, Blimp1 and Prdm14, are induced by BMP/LIF signaling both in vivo and in vitro. However, SMAD1 is not present at their promoters or enhancers [81, 82] . One simple explanation would be that the genome-wide DNA demethylation, active or passive, promoted by BMP somehow stimulates expression of Blimp1 and Prdm14. But how BMP signaling induce genome-wide DNA demethylation is not clear. The base pair resolution mapping of oxidized methyl-cytosine (hmC, fC, caC) in mESC has shown that the active demethylation dynamics around the SMAD1 binding region differs from that around other TF binding region [83] . This suggests that SMAD1 recruits other factor(s) that promote the active DNA demethylation. Therefore, the discovery of such factors is the key to understanding how BMP signal induces genome-wide DNA demethylation.
SMAD and Chromatin Reader
As we described above, TGF-β signaling actively changes the epigenome through recruiting or regulating writers and erasers of histone modification and DNA modification. And, chromatin readers also bridge the crosstalk between signaling and epigenome. One of such readers TRIM33 [84, 85] is a member of larger tripartite motif family of protein, and has PHD and Bromo domains at its C terminus, suggesting it functions through interacting with the modified histone tail [86, 87] . At the N terminus, TRIM33 protein has a RBCC domain, which has been shown to have ubiquitin or sumo E3 ligase activity [88, 89] . Its flexible middle region can bind to the MHII domain of SMAD2/3 protein to form a transcription regulatory complex in TGF-β signaling-dependent manner. During gastrulation of mouse embryo, TRIM33 is highly expressed in epiblast cells. Loss of function studies indicated that the TRIM33-SMAD2/3 complex plays a key role in mesendoderm differentiation of both mouse and human ESCs. In the context of the TRIM33-SMAD2/3 complex, TRIM33 utilizes its PHD-Bromo cassette to bind the dual histone marks H3K9me3 and K18ac on the regulatory regions of mesendoderm regulators Gsc and Mixl1. This interaction has been characterized using crystallography of the TRIM33 PHD-Bromo cassette bound to the modified histone H3 peptides. It has been proposed that binding of TRIM33-SMAD2/3 to H3K9me3 displaces the chromatin compacting factor HP1γ and makes nodal response elements accessible to SMAD4-SMAD2/3 for Pol II recruitment. In turn, SMAD4 increases K18 acetylation to augment TRIM33-SMAD2/3 binding. Thus, nodal uses the H3K9me3 mark as a platform to switch master regulator genes of stem cell differentiation from the poised to the active state [84, 85] . TRIM33, therefore, serves as a bridging molecule that links signal transduction with epigenetic landscape remodeling of the cell, and this may constitute a robust mechanism for cell fate determination.
Does a similar crosstalk mechanism exist in BMP signaling? It is well known that BMP signaling is involved in mESCs self-renewal and mesoderm, ectoderm differentiation. Genome-wide ChIP-seq analyses of SMAD1/5 and SMAD4 in mESCs revealed that SMAD4 occupies more genes than SMAD1/5 does, and significant portions of SMAD1/ 5-bound genes are not occupied by SMAD4 [66] . This interesting finding raises the possibility that in BMP signaling SMAD1/5 can function in a SMAD4-independent manner, analogous to the fact that, in TGF-β signaling, TRIM33 forms a SMAD4-independent complex with SMAD2/3. TRIM33 could not be a candidate to interact with SMAD1/5 [85] , suggesting the existence of a TRIM33-equivalent protein in BMP signaling pathway, which might serve as a specific chromatin reader to bridge BMP signaling with the epigenome.
Long Non-coding RNAs
Long non-coding RNAs (lncRNAs), which often are more than 200 nucleotides long and cannot be translated into proteins, have recently been found to play important roles in cell development and differentiation. A major function of lncRNAs is to facilitate epigenetic regulation of gene expression by coupling with chromatin regulators such as chromatin modifiers and remodelers [90] . Several recent reports have demonstrated that lncRNAs are regulators for important lineage specific genes [91] [92] [93] [94] . As described above, a chromatin reader TRIM33 can mediate the crosstalk between TGF-β signaling pathway and the epigenome during murine embryonic stem cell differentiation [84] . Given their unique features such as high sequence specificity and strong chromatin association, lncRNAs could be another set of candidates for mediating the crosstalk between TGF-β signaling and the epigenome. But, whether lncRNAs could play such a role is not known.
The lncRNA DIGIT, whose expression is induced by TGF-β signaling, has been found to convert the developmental cues of TGF-β signal into transcriptional regulation. Daneshvar et al. [95] have identified R-SMAD regulated lncRNA transcripts by analyzing both RNA-seq and ChIP-seq data of endodermal differentiated cells. Of the most interest, DIGIT, a divergent lncRNA transcript at GSC locus, is induced by TGF-β signaling during endodermal differentiation. Loss of function study indicated that deletion of DIGIT locus leads to a defect in definitive endoderm differentiation [95] . Although the exact regulating mechanism is not included in this paper, it gives us the clues that TGF-β signaling could regulate differentiation process through inducing lncRNAs. Another lncRNA identified to be regulated by TGF-β signaling is lncRNA ATB [96] .
It plays an important role in the epithelial to mesenchymal transition of hepatocellular carcinoma. In contrast to DIGIT, lncRNA ATB localizes in the cytoplasm and mainly regulates the stability of miR-200 family which plays crucial roles in the regulation of epithelialmesenchymal transition through targeting ZEB1/2 mRNA. And recently the same lncRNA has been found to promote drug resistant in breast cancer [97] . Therefore, TGF-β signaling induce lncRNA may function as a fine-tuning player in the pathway, which exerts its epigenetic effects on gene expression.
Conclusions and Perspectives
Cell signaling in general is regulated in a cell context-dependent manner. Consistent with epigenetic landscape hypothesis proposed by Waddington, epigenetic regulators have been shown to be critical factors that determine cell signaling responses, especially in temporal and spatial regulation during development.
With the advance of next generation sequencing technology, the epigenome can be mapped to an even finer detail, which has led to a greater appreciation of how the epigenome interplays with cell signaling to influence development and disease progression. In the nucleus, the central player of the TGF-β pathway, R-SMADs, interplays with epigenome through recruiting epigenetic regulators, such as chromatin remodelers, histone modifiers, DNA modifiers, chromatin readers, and lncRNAs, to the target gene regulatory elements. In some cases, epigenetic regulators are among the target genes and are induced by R-SMADs. These findings will help us appreciate how the versatile functions of TGF-β signaling are regulated in cell context-dependent manner by crosstalking with epigenome. Better understanding of how TGF-β signaling governs the epigenome will eventually help us develop novel therapeutic applications to treat diseases.
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